A Case Report on Therapeutic Optimization and Cardiometabolic Benefits of Semaglutide Therapy in Type 2 Diabetes Mellitus: Case Report. Journal of Pharma Insights and Research, [S. l.], v. 4, n. 2, p. 252–258, 2026. DOI: 10.69613/ss2yp015. Disponível em: https://staging.jopir.in/index.php/journals/article/view/742. Acesso em: 19 may. 2026.